Publications by authors named "Mathieu Desaunay"

Claim this Profile
D
Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML.
Lise Brault, Edwige Voisset, Mathieu Desaunay, Antonia Boudet, Paraskevi Kousteridou

EMBO Mol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS mutation-specific responses to paralog- and state-selective RAS inhibitors.
Beau Baars, Ana Orive-Ramos, Matthew J Emmett, Bijaya Gaire, Mathieu Desaunay

Mol Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming melanoma therapy resistance with RAF-MEK and FAK inhibition.
Mathieu Desaunay, Poulikos I Poulikakos

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS mutation-specific signaling dynamics in response to paralog- and state- selective RAS inhibitors.
Beau Baars, Ana Orive-Ramos, Ziyue Kou, Bijaya Gaire, Mathieu Desaunay

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors.
Mathieu Desaunay, Edwige Voisset, Sebastien Letard, Philippe Roche, Paulo De Sepulveda

Cell Mol Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis